Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33811
Title: Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.
Austin Authors: Li Wai Suen, Christopher F D;Seah, Dean ;Choy, Matthew C ;De Cruz, Peter P 
Affiliation: Gastroenterology and Hepatology
Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, VIC, Australia.
Issue Date: 19-Sep-2023
Date: 2023
Publication information: Inflammatory Bowel Diseases 2023-09-19
Abstract: Acute severe ulcerative colitis (ASUC) is a medical emergency for which colectomy is required in patients who do not respond to rescue therapy. While previous studies have predominantly focused on predicting outcome to first-line corticosteroid therapy, there is a need to understand the factors associated with response to rescue therapies in order to improve clinical outcomes. We reviewed the evidence regarding factors associated with response to rescue therapy in adults with ASUC and identified future directions for research. A systematic search of the literature was conducted, and 2 reviewers independently assessed studies for inclusion. Of 3509 records screened, 101 completed studies were eligible for inclusion. We identified 42 clinical, hematological, biochemical, endoscopic, or pharmacological factors associated with response to rescue therapy. Older age (≥50 years), thiopurine experience, and cytomegalovirus or Clostridioides difficile infection were associated with a higher risk of nonresponse to rescue therapy. Biochemical factors associated with poorer response included an elevated C-reactive protein (CRP) ≥30mg/L on admission, hypoalbuminemia and an elevated ratio of CRP to albumin. Severe endoscopic findings, including a Mayo endoscopic score of 3 or Ulcerative Colitis Endoscopic Index of Severity ≥5, portended poorer outcomes. The role of fecal calprotectin and therapeutic value of measuring infliximab drug levels in ASUC remain to be defined. Response to rescue therapy can be predicted by several specific factors, which would aid clinical decision-making. Existing and emerging factors should be integrated within predictive and prognostic models to help improve clinical outcomes.
URI: https://ahro.austin.org.au/austinjspui/handle/1/33811
DOI: 10.1093/ibd/izad183
ORCID: 0000-0003-4095-1153
0000-0003-3317-1888
0000-0001-5206-0097
0000-0002-3399-7236
Journal: Inflammatory Bowel Diseases
PubMed URL: 37725044
ISSN: 1536-4844
Type: Journal Article
Subjects: acute severe ulcerative colitis
colectomy
cyclosporin
infliximab
prognosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

40
checked on Nov 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.